• Users Online: 192
  • Print this page
  • Email this page
  • Email this page
  • Email this page
  • Email this page
REVIEW ARTICLE
Year : 2022  |  Volume : 1  |  Issue : 4  |  Page : 196-202

Clinical pharmacology of cefazolin


via Sant’Andrea 32, Pisa, Italy

Correspondence Address:
Prof. Gian Maria Pacifici
via Sant’Andrea 32, 56127 Pisa
Italy
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/abhs.abhs_31_22

Rights and Permissions

Cefazolin is a first-generation cephalosporin that is active against gram-positive bacteria and has modest activity against gram-negative organisms, and cefazolin is excreted by glomerular filtration. The efficacy and safety of cefazolin and cefazolin concentration in body tissues have been described. Cefazolin pharmacokinetics have been studied; six patients received cefazolin at a dose of 1 g thrice daily and one patient received cefazolin at a dose of 2 g once daily and this patient had acute kidney injury. The pharmacokinetics of cefazolin have been studied. The prophylaxis, treatment, and trials with cefazolin have been reported. The penetration of cefazolin into the cerebrospinal fluid has been studied. Cefazolin treats the meningitis caused by Staphylococcus meningitis or by methicillin-susceptible S. aureus and cefazolin may become resistant to bacteria. Cefazolin freely crosses the human placenta and poorly migrates into the breast milk. The aim of this review was to describe cefazolin efficacy and safety, tissue concentration, pharmacokinetics, prophylaxis, treatment, trials, penetration into the cerebrospinal fluid, treatment of bacterial meningitis, resistance, transfer across the human placenta, and migration into the breast milk.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed769    
    Printed64    
    Emailed0    
    PDF Downloaded46    
    Comments [Add]    

Recommend this journal